Original Research
Published on 17 Jan 2022
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients
- 5,764 views
- 11 citations
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Editorial
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Original Research
Published on 17 Jan 2022
Systematic Review
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Review
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Mini Review
Published on 14 Jan 2022
Review
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Brief Research Report
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Original Research
Published on 14 Jan 2022
Systematic Review
Published on 14 Jan 2022